GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Artivion Inc (NYSE:AORT) » Definitions » Price-to-Free-Cash-Flow

AORT (Artivion) Price-to-Free-Cash-Flow : 86.51 (As of Dec. 12, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Artivion Price-to-Free-Cash-Flow?

As of today (2024-12-12), Artivion's share price is $29.50. Artivion's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.34. Hence, Artivion's Price-to-Free-Cash-Flow Ratio for today is 86.51.

The historical rank and industry rank for Artivion's Price-to-Free-Cash-Flow or its related term are showing as below:

AORT' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 26.39   Med: 74.55   Max: 2866.36
Current: 86.5

During the past 13 years, Artivion's highest Price-to-Free-Cash-Flow Ratio was 2866.36. The lowest was 26.39. And the median was 74.55.

AORT's Price-to-Free-Cash-Flow is ranked worse than
83.43% of 350 companies
in the Medical Devices & Instruments industry
Industry Median: 32.945 vs AORT: 86.50

Artivion's Free Cash Flow per Share for the three months ended in Sep. 2024 was $0.19. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.34.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 28.20% per year.

During the past 13 years, Artivion's highest 3-Year average Free Cash Flow per Share Growth Rate was 38.70% per year. The lowest was -36.50% per year. And the median was -6.40% per year.


Artivion Price-to-Free-Cash-Flow Historical Data

The historical data trend for Artivion's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artivion Price-to-Free-Cash-Flow Chart

Artivion Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 132.15 177.52 - - 63.86

Artivion Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 63.86 68.48 91.61 78.06

Competitive Comparison of Artivion's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Artivion's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Artivion's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Artivion's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Artivion's Price-to-Free-Cash-Flow falls into.



Artivion Price-to-Free-Cash-Flow Calculation

Artivion's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=29.50/0.341
=86.51

Artivion's Share Price of today is $29.50.
Artivion's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.34.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Artivion  (NYSE:AORT) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Artivion Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Artivion's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Artivion Business Description

Traded in Other Exchanges
Address
1655 Roberts Boulevard North West, Kennesaw, GA, USA, 30144
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
Executives
Andrew M Green officer: VP Regulatory ARTIVION INC, 1655 ROBERTS BLVD, KENNESAW GA 30144
Amy Horton officer: Chief Accounting Officer C/O CRYOLIFE, INC., 1655 ROBERTS BLVD., NW, KENNESAW GA 30144
Jean F Holloway officer: VP, General Counsel C/O ARTIVION INC, 1655 ROBERTS BLVD, KENNESAW GA 30144
Matthew A Getz officer: VP, Human Resources 1655 ROBERTS BLVD NW, KENNESAW GA 30144
Anthony B. Semedo director 3288 HARRISON GRADE ROAD, SEBASTOPOL CA 95472
Marshall S. Stanton officer: SVP, Clinical & MD Affair 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Rochelle L. Maney officer: VP, Quality 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
John E Davis officer: Senior VP, Global Sales 1655 ROBERTS BLVD., NW, KENNESAW GA 30144
James P Mackin officer: President & CEO ARTIVION, INC., 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Florian Tyrs officer: VP, Global Operations IM SOELLER 3, BALINGEN 2M 72336
Robert C Thomson officer: VP Research & Development 33 HABERSHAM COVE DRIVE, NW, ATLANTA GA 30305
Dennis B Maier officer: Vice President, Operations 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
David Ashley Lee officer: Executive VP, COO & CFO C/O CRYOLIFE INC, 1655 ROBERTS BLVD NW, KENNESAW GA 30144
Elizabeth A Hoff director 2701 WESTHEIMER ROAD, UNIT 1-E, HOUSTON TX 77098
Ronald D Mccall director C/O CRYOLIFE, INC., 1655 ROBERTS BOULEVARD, NW, KENNESAW GA 30144